Brachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy

Similar documents
Brachytherapy an Overview

Brachytherapy. What is brachytherapy and how is it used?

Brachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w

Brachytherapy Planning and Quality Assurance

Regulatory Guidelines and Computational Methods for Safe Release of Radioactive Patients II. Brachytherapy

How ICD-10 Affects Radiation Oncology. Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA

Radioactive sources in brachytherapy

Definitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN

FEE RULES RADIATION ONCOLOGY FEE SCHEDULE CONTENTS

INTRODUCTION TO BRACHYTHERAPY, HISTORY AND INDICATIONS. Christine Haie-Meder Brachytherapy Unit

2015 Radiology Coding Survival Guide

BRACHYTHERAPY IN HORSES

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Chapter 13: Brachytherapy: Physical and Clinical Aspects

A Study on Dosimetry of Gynaecological Cancer and Quality Assurance of HDR Brachytherapy in BPKMCH, Nepal

Varian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy

BRACHYTHERAPY IN HEAD & NECK CANCERS DR. GIRI G.V.

Radiotherapy physics & Equipments

MultiSource. for a higher standard in HDR brachytherapy.

Review of brachytherapy in

Comprehensive and Practical Brachytherapy March 04-8 March 2018, Ljubljana, Slovenia Day 1 Sunday 4 March 2018

OPPORTUNITIES IN BRACHYTHERAPY

I. Equipments for external beam radiotherapy

Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP and ACRO

The Future of Brachytherapy. Alex Rijnders Europe Hospitals Brussels, Belgium

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป


Radiation Biology in Brachytherapy

RADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS

GYNECOLOGIC CANCER and RADIATION THERAPY. Jon Anders M.D. Radiation Oncology

Basics of Cervix Brachytherapy. William Small, Jr., MD Professor and Chairman Loyola University Chicago

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Intravascular Brachytherapy Dosimetry Techniques for Gamma systems

MEDICAL MANAGEMENT POLICY

3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA

12 Physics and Clinical Aspects of Brachytherapy

Pulsed Dose Rate for GYN Brachytherapy

The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 11, 2015

Clinical Applications of Brachytherapy Radiobiology. Radiobiology is Essential

HDR vs. LDR Is One Better Than The Other?

Radio-isotopes in Clinical Medicine

Who Should Know Radiation Oncology Coding?

Brachytherapy, Radionuclide Therapy Medical Physics in the Clinic. Raymond K. Wu, PhD Chairman AAPM Exchange Scientist Program

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS

Prostate Cancer. What is prostate cancer?

Prostate Cancer Treatment

Brachytherapy:General Principles

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

Medical Use of Radioisotopes

X-ray Safety Discussion and Tour for Health Physicists

EORTC Member Facility Questionnaire

National System for Incident Reporting in Radiation Therapy (NSIR-RT) Taxonomy

Cervical Cancer Treatment

Practice and Risk at Medical Facilities in Agency Operations

MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Overview of Clinical and Research Activities at Georgetown University Hospital

University Medical Center Utrecht The Netherlands

Advances in Treatment of Cancer by Brachytherapy in Kenya, in Particular, Prostate Cancer

Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April

Interstitial Breast Brachytherapy

Inpatient Admission for Radiation Therapy

MEDICAL POLICY. SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER POLICY NUMBER: CATEGORY: Technology Assessment

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005

Cigna Medical Coverage Policy

20 Prostate Cancer Dan Ash

PROGRESS IN RADIATION ONCOLOGY. Fox Chase Cancer Center. Jean Holland RN MSN AOCN Department of Radiation Oncology April 2017

Prostate Cancer. What is prostate cancer?

APPLICATIONS OF RADIATION IN MEDICINE. Kirstin Murray BSc (Hons) Radiotherapy & Oncology

TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY

Online in vivo dosimetry in conformal radiotherapies with MOSkin detectors

IAEA-TECDOC Implementation of microsource high dose rate (mhdr) brachytherapy in developing countries

Understanding Radiation Therapy. For Patients and the Public

Dosimetric Characteristics of the Brachytherapy Sources Based on Monte Carlo Method

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

Patient Safety Focused QA. LDR Brachytherapy Vrinda Narayana

Regions Hospital Delineation of Privileges Radiation Oncology

NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning

RADIATION ONCOLOGY AT UNIVERSITY OF COLORADO HOSPITAL

Radiation Safety Information for Students in Courses given by the Nuclear Physics Group at KTH, Stockholm, Sweden

Wireless In-Vivo Dosimetry of High Dose Rate Brachytherapy for Prostate Cancer using MOSkin Detectors

Dosimetric characteristics of 137 Cs sources used in after loading Selectron system by Monte Carlo method

Bell in 1903 was first suggested implanting. First Report on Study of Quality Control Program of High Dose Rate (Hdr) Brachytherapy.

Option D: Medicinal Chemistry

Breast Cancer. What is breast cancer?

Quality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St.

Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande

Radiation Therapy for Cancer: Questions and Answers

Radiation Protection in Laboratory work. Mats Isaksson, prof. Department of radiation physics, GU

Atoms for Health. Atoms for Health The. Atoms for Health - Division of Nuclear Health - Dept of Nuclear Aplications P Andreo DIR-NAHU 1

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Image based Brachytherapy- HDR applications in Gynecological Tumors

Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy

WN MEDICAL IMAGING. RADIOTHERAPY. MEDICAL PHYSICS. NUCLEAR MEDICINE. RADIOACTIVITY

PROSTATE CANCER BRACHYTHERAPY. Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College

Application of the Commission's Recommendations for the Protection of People in

Accelerated Partial Breast Irradiation. Dr Patricia Lillis MD, MHA,MSS Marshfield Clinic Radiation Oncology

Transcription:

Brachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy Interstitial Seven 192-Ir wires Interstitial implant for breast radiotherapy

Intracavitary Three 137-Cs sources Intracavitary gynecological implant

Brachytherapy overview Brachytherapy uses encapsulated radioactive sources to deliver a high dose to tissues near the source brachys (Greek) = short (distance) Inverse square law determines most of the dose distribution

Brachytherapy Characterized by strong dose gradients Many different techniques and sources available Implants are highly customized for individual patients

Brachytherapy Use of radioactive materials in direct contact with patients - more radiation safety issues than in external beam radiotherapy Less than 10% of radiotherapy patients are treated with brachytherpay Per patient treated the number of accidents in brachytherapy is considerably higher than in EBT

Contents Brachytherapy Sources and equipment Brachytherapy techniques

Brachytherapy Sources and Equipment Objectives To understand the concept of sealed source To know the most common isotopes used for brachytherapy To be familiar with general rules for source handling and testing To be aware of differences between permanent implants, low (LDR) and high dose rate (HDR) applications To understand the basic fundamentals of brachytherapy equipment design.

1. Sealed sources IAEA BSS glossary: Radioactive material that is a) permanently sealed in a capsule or b) closely bound and in a solid form. In other words: the activity is fixed to its carrier and contamination of the environment is not possible as long as the source is intact Have an activity which can be derived from a calibration certificate and the half life of the isotope (nothing is lost) MUST be checked for integrity regularly - a good means of doing this is by wipe tests

Sealed and unsealed sources in radiotherapy Both are used to treat cancer Sealed sources are used for EBT and Brachytherapy - the Brachytherapy sources are discussed here Unsealed sources may be used for systemic treatments (Nuclear Medicine) as: 131-I for thyroid treatment 89-Sr and 153-Sm for treatment of bone metastasis.

2. The ideal source in Brachytherapy What do you think one would expect from and ideal Brachytherapy source? Clinical usefulness determined by Half life = the time after which half of the original activity is still present in the source Specific activity = activity per gram of material. The higher the smaller a source of a particular activity can be made Radiation energy determines the range of radiation in tissue (AND the requirements for shielding)

The Ideal Brachytherapy source Pure gamma emitter - betas or alphas are too short in range and result in very high doses to small volumes around the source Medium gamma energy high enough to treat the target with homogenous dose low enough to avoid normal tissues and reduce shielding requirements High specific activity suitable also for high dose rate applications small

The Ideal Brachytherapy source Stable daughter product For مؤقتtemporary implants: long half life allows economical re-use of sources For permanent implants: medium half life

3. Real brachytherapy Sources A variety of source types and isotopes are currently in use They differ for different applications because of half life, size (specific activity) and radiation energy When deciding on a source one must also keep the shielding requirements in mind.

Brachytherapy Sources Radionuclide Half-life Photon Energy (MeV) Half-value Layer (mm lead) 226 Ra 1600 years 0.047-2.45 (0.83 ave) 8.0 222 Rn 3.83 days 0.047-2.45 (0.83 ave) 8.0 60 Co 5.26 years 1.17, 1.33 11.0 137 Cs 30.0 years 0.662 5.5 192 Ir 74.2 days 0.136-1.06 (0.38 ave) 2.5 198 Au 2.7 days 0.412 2.5 125 I 60.2 days 0.028 ave 0.025 103 Pd 17.0 days 0.021 ave 0.008

Brachytherapy sources The first isotope used clinically was radium around 1903 However, radium and radon have only historical importance - they should not be used in a modern radiotherapy department

Brachytherapy sources Because: wide energy spectrum leading to high dose close to the source and still high dose around the patient - shielding difficult Radon, the daughter product of radium, is a noble gas which is very difficult to contain - contamination risk The long half life means disposal is very difficult

Popular sources: 137-Cs Cesium 137 Main substitute for radium Mostly used in gynecological applications Long half life of 30 years ---> decay correction necessary every 6 months Sources are expensive and must be replaced every 10 to 15 years

Popular sources: 192-Ir Iridium 192 Many different forms available Most important source for HDR applications Medium half life (75 days) - decay correction necessary for each treatment Needs to be replaced every 3 to 4 months to maintain effective activity and therefore an acceptable treatment time

Popular sources: 192-Ir Iridium 192 High specific activity - therefore even high activity sources can be miniaturized essential for HDR applications A bit easier to shield than 137-Cs - because the gamma energies of 192-Ir range from 136 to 1062keV (effective energy around 350keV)

Popular sources: 125-I Very low energy - therefore shielding is easy and radiation from an implant is easily absorbed in the patient: permanent implants are possible Mostly used in the form of seeds

125-I seeds Many different designs

125-I seeds Design aims and features: sealed source non-toxic tissue compatible encapsulation isotropic dose distribution radio-opaque for localization Mentor

X-ray visibility of 125-I seeds

Other isotopes used for seeds Palladium 103 Half Life = 17 days - dose rate about 2.5 times larger than for 125-I Energy = 22 kev TVL lead = 0.05mm Gold 198 Half Life = 2.7 days - short enough to let activity decay in the patient Energy = 412 kev TVL lead = around 8mm

Brachytherapy Sources A variety of source shapes and forms: pellets = balls of approximately 3 mm diameter seeds = small cylinders about 1 mm diameter and 4 mm length needles = between 15 and 45 mm active length tubes = about 14 mm length, used for gynaecological implants hairpins = shaped as hairpins, approximately 60 mm active length wire = any length, usually customised in the hospital - inactive ends may be added HDR sources = high activity miniature cylinder sources approximately 1mm diameter, 10mm length

Source form examples Seeds (discussed before): small containers for activity usually 125-I, 103-Pd or 198-Au for permanent implant such as prostate cancer Needles and hairpins: Scale in mm for life implants in the operating theatre - activity is directly introduced in the target region of the patient usually 192-Ir for temporary implants eg. of the tongue

Source form: 192-Ir wire Used for LDR interstitial implants Cut to appropriate length prior to implant to suit individual patient Cutting using manual technique or cutter...

Source form 192-Ir wires 192-Ir wire: activity between 0.5 and 10mCi per cm used for interstitial implants low to medium dose rate can be cut from 50 cm long coils to the desired length for a particular patient Length measurement Movement controls Shielding Wire cutter

Source form example 192-Ir wire: activity between 0.5 and 10mCi per cm used for interstitial implants low to medium dose rate can be cut from 50 cm long coils to the desired length for a particular patient Length measurement Movement controls Shielding Wire cutter

Question: Why would people use 198-Au for brachytherapy?

Some clues for an answer Key features of 198-Au are: small sources (seed) short half life (2.7 days) inert material photon energy 412keV Therefore, ideal for permanent implant

Brachytherapy Brachytherapy installations cover direct source loading 137-Cs sources for gynaecological applications (radium should not be used) permanent seed implants (gold or 125-I) surface applicators (moulds, 125-I, strontium and ruthenium plaques manual afterloading (137-Cs, 192-Ir) automatic afterloading (LDR, PDR and HDR)

Brachytherapy Highly customized treatment techniques - each patient is treated differently Techniques depend on Disease site and stage Operator/clinician Technology/equipment available Many of the points covered for External Beam installations also apply to Brachytherapy installations, particularly for automatic afterloading systems

Preparation of sources for brachytherapy Choosing the correct sources is an important part of the implant optimization This is applicable for situations when: there are several different sources available (eg 137-Cs source with slightly different length and activity for gynecological implants) sources are ordered and customized for an individual patient (eg. 192-Ir wire)

Require a pre-implant plan...

Choosing the correct sources Prepare a plan for a particular implant following the prescription Select appropriate sources If existing sources are to be used select sources from the safe and place in transport container Document what is done source safe shielding

Interstitial implants For LDR usually use 192-Ir wire (compare part VI) Optimization is possible as the length of the wire can be adjusted for a particular implant

HDR sources No preparation necessary Ensure source calibration optimized plan

Implant techniques Permanent implants patient discharged with implant in place Temporary implants implant removed before patient is discharged Here particular emphasis on radiation protection issues in medical exposures

Permanent Implants: Radiation protection issues Implant of activity in theatre: Radiation protection of staff from a variety of professional backgrounds - radiation safety training is essential RSO or physicist should be present Source transport always necessary Potential of lost sources

Problems with handling activity in the operating theatre The time to place the sources in the best possible locations is typically limited Work behind shields or with other protective equipment may prolong procedure and result in sub-optimal access to the patient

Working behind shields

Permanent Implants: Radiation protection issues Patients are discharged with radioactive sources in place: lost sources exposure of others issues with accidents to the patient, other medical procedures, death, autopsies and cremation - compare part XV of the course

Temporary implants Mostly done in afterloading technique Radiation safety issues for staff: Source handling and preparation Exposure of nursing staff in manual afterloading Radiation safety issues for patients: Source placement and removal

Afterloading Manual The sources are placed manually usually by a physicist The sources are removed only at the end of treatment Remote The sources are driven from an intermediate safe into the implant using a machine ( afterloader ) The sources are withdrawn every time someone enters the room

Afterloading advantages No rush to place the sources in theatre - more time to optimize the implant Treatment is verified and planned prior to delivery Significant advantage in terms of radiation safety (in particular if a remote afterloader is used)

Use of lead shield reduces scatter to the patient

High Dose Rate Brachytherapy Most modern brachytherapy is delivered using HDR Reasons? Outpatient procedure Optimization possible

HDR brachytherapy In the past possible using 60-Co pellets Today, virtually all HDR brachytherapy is delivered using a 192-Ir stepping source Source moves step by step through the applicator - the dwell times in different locations determine the dose distribution

HDR unit interface

4. Brachytherapy equipment Design considerations often similar to external beam therapy Nucletron

Remote Afterloading Equipment The most complex pieces of equipment in brachyhterapy Low dose rate units High dose rate units Many important design consideration in IEC standard

Low dose rate brachytherapy Selectron for gynecological brachytherapy 137-Cs pellets pushed into the applicators using compressed air Location of active and inactive pellets can be chosen by the operator to optimize the source loading for an individual patient Shown are 6 channels - the red lights indicate the location of an active source Nucletron

Other features No computer required Two independent timers Optical indication of source locations Permanent record through printout Key to avoid unauthorized use

HDR brachytherapy units Must be located in a bunker Have multiple channels to allow the same source to drive into many catheters/needles MDS Nordion

Nucletron HDR unit control Emergency off button Keypad Printout = permanent record Display Key Key for source out Memory card for transfer of the dwell positions for the treatment of a particular patient - labeled

Catheters are indexed to avoid mixing them up Transfer catheters are locked into place during treatment - green light indicates the catheters in use

Regular maintenance is required Source drive must be working within specified accuracy (typically 1-2mm) Emergency buttons must work Manual retraction of the source in case of power failure must work

Regular maintenance is required Maintenance work should follow manufacturers recommendations All modifications MUST be documented A physicists should be notified to perform appropriate tests

LDR and HDR units are not all... Other brachytherapy equipment: PDR (pulsed dose rate) units Seed implant equipment Endovascular brachytherapy

LDR and HDR units are not all... Other brachytherapy equipment: PDR units - similar to HDR Seed implant equipment - discussed in more detail in the second lecture of part VI Endovascular brachytherapy

Typical Radiation Levels Selectron LDR (Cs-137) Cervix insertion 10 pellets of 15 mci/seed = 150 mci 20 mr/h at 1m 0.2 msv/h 5 days for 1 msv (Background) this is inside the room! microselectron HDR (Ir-192) turned ON! 10 Ci source = 10 000 mci 4700 mr/h at 1m 47 msv/h 1.3 minutes for 1 msv (Background) door interlock ensures that no-one is in room

Brachytherapy Techniques 1. Clinical brachytherapy applications 2. Implant techniques and applicators 3. Delivery modes and equipment

Brachytherapy Very flexible radiotherapy delivery Source position determines treatment success Depends on operator skill and experience In principle the ultimate conformal radiotherapy Highly individualized for each patient Typically an inpatient procedure as opposed to external beam radiotherapy which is usually administered in an outpatient setting

Clinical brachytherapy

History Brachytherapy has been one of the earliest forms of radiotherapy After discovery of radium by M Curie, radium was used for brachytherapy already late 19th century There is a wide range of applications - this versatility has been one of the most important features of brachytherapy

Today Many different techniques and a large variety of equipment Less than 10% of radiotherapy patients receive brachytherapy Use depends very much on training and skill of clinicians and access to operating theatre

A brachytherapy patient Typically localized cancer Often relatively small tumor Often good performance status (must tolerate the operation) Sometimes pre-irradiated with external beam radiotherapy (EBT) Often treated with combination brachytherapy and EBT

1. Clinical brachytherapy applications A. Surface moulds B. Intracavitary (gynaecological, bronchus,..) C. Interstitial (Breast, Tongue, Sarcomas, )

A. Surface moulds Treatment of superficial lesions with radioactive sources in close contact with the skin Hand A mould for the back of a hand including shielding designed to protect the patient during treatment Catheters for source transfer

Surface mould advantages Fast dose fall off in tissues Can conform the activity to any surface Flaps available

B. Intracavitary implants Introduction of radioactivity using an applicator placed in a body cavity Gynaecological implants Bronchus Oesophagus Rectum

Gynaecological implants Most common brachytherapy application - cervix cancer Many different applicators Either as monotherapy or in addition to external beam brachytherapy as a boost

Gynecological applicators Different design - all Nucletron

Vaginal applicators Single source line Different diameters and length Gammamed - on the right with shielding Nucletron

Bronchus implants Often palliative to open air ways Usually HDR brachytherapy Most often single catheter, however also dual catheter possible

Dual catheter bronchus implant Catheter placement via bronchoscope Bifurcation may create complex dosimetry

C. Interstitial implants Implant of needles or flexible catheters directly in the target area Breast Head and Neck Sarcomas Requires surgery - often major

Interstitial implants - tongue implant Catheter loop tongue tongue Button

Breast implants Typically a boost Often utilizes templates to improve source positioning Catheters or needles

2. Implant techniques and applicators Permanent implants patient discharged with implant in place Temporary implants implant removed before patient is discharged from hospital

Source requirement for permanent implants Low energy gammas or betas to minimize radiation levels outside of the patient (125-I is a good isotope) May be short-lived to reduce dose with time (198-Au is a good isotope) More details on most common 125-I prostate implants in section 4A of the lecture

Temporary implants Implant of activity in theatre Manual afterloading Remote afterloading

3. Delivery modes and equipment Low Dose Rate (LDR) Medium Dose Rate High Dose Rate (HDR) Pulsed Dose Rate (PDR)

Delivery modes - different classifications are in use Low Dose Rate Medium Dose Rate High Dose Rate Pulsed Dose Rate < 1Gy/hour around 0.5Gy/hour > 1Gy/hour not often used >10Gy/hour pulses of around 1Gy/hour

Low dose rate brachytherapy The only type of brachytherapy possible with manual afterloading Most clinical experience available for LDR brachytherapy Performed with remote afterloaders using 137-Cs or 192-Ir

Low dose rate brachytherapy Selectron for gynecological brachytherapy 137-Cs pellets pushed into the applicators using compressed air 6 channels for up to two parallel treatments Nucletron

Simple design No computer required Two independent timers Optical indication of source locations Permanent record through printout Key to avoid unauthorized use

Treatment process Implant of applicator (typically in the operating theatre) Verification of applicator positioning using diagnostic X-rays (eg radiotherapy simulator)

Treatment planning Most commercial treatment planning systems have a module suitable for brachytherapy planning: Choosing best source configuration Calculate dose distribution Determine time required to give desired dose at prescription points Record dose to critical structures

Treatment planning of different brachytherapy implants

High Dose Rate Brachytherapy Most modern brachytherapy is delivered using HDR Reasons? Outpatient procedure Optimization possible

HDR brachytherapy In the past possible using 60-Co pellets Today, virtually all HDR brachytherapy is delivered using a 192-Ir stepping source Source moves step by step through the applicator - the dwell times in different locations determine the dose distribution

HDR 192-Ir source Source length 5mm, diameter 0.6mm Activity: around 10Ci From presentation by Pia et al

Optimization of dose distribution adjusting the dwell times of the source in an applicator Nucletron

HDR brachytherapy procedure Implant of applicators, catheters or needles in theatre For prostate implants as shown here use transrectal ultrasound guidance

HDR brachytherapy procedure Localization using diagnostic X-rays HDR prostate implant: Simulator image Scout image for CT scan

Treatment planning Definition of the desired dose distribution (usually using many points) Computer optimization of the dwell positions and times for the treatment

Treatment Transfer of date to treatment unit Connecting patient Treat... Gammamed Nucletron

HDR unit interface

HDR brachytherapy Usually fractionated (eg. 6 fractions of 6Gy) Either patient has new implant each time or stays in hospital for bi-daily treatments Time between treatments should be >6hours to allow normal tissue to repair all damage

HDR units: different designs available

Catheters are indexed to avoid mixing them up Transfer catheters are locked into place during treatment - green light indicates the catheters in use

HDR systems Can be moved eg between different facilities or into theatre for intraoperative work

Pulsed dose rate Unit has a similar design as HDR, however the activity is smaller (around 1Ci instead of 10Ci) Stepping source operation - same optimization possible as in HDR Treatment over same time as LDR treatment to mimic favorable radiobiology In-patient treatment: hospitalization required Source steps out for about 10 minutes per hour and then retracts. Repeats this every hour to deliver minifractions ( pulses ) of about 1Gy

Feras Mansour Jargon فراس منصور جرغون IAEA Training Course: Radiation Protection in Radiotherapy slide 109